Prostate Cancer Screening: What’s Gone Wrong? What Can We Get Right?
Join us on Wednesday, October 29 for the Epidemiology Seminar Series, featuring Dr. Kevin Kensler discussing Prostate Cancer Screening: What’s Gone Wrong? What Can We Get Right?
Abstract: Prostate cancer screening is at a crossroads. Despite evidence that screening prostate-specific antigen (PSA) can reduce advanced disease and mortality, current practices too often overscreen older men while underserving those at highest risk. This seminar will examine where prostate cancer screening has gone wrong and highlight opportunities for more targeted, equitable approaches to early detection.
Bio: Kevin Kensler, ScD, MHS, is an Assistant Professor in the Department of Population Health Sciences at Weill Cornell Medicine and member of the Cancer Prevention and Control program at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. His research focuses on prostate cancer epidemiology, with emphasis on screening, disparities, survivorship, and molecular heterogeneity. He has examined how changes in screening guidelines have shaped trends in advanced disease, particularly across socioeconomic and racial groups, and uses large-scale population and clinical data to study risk and prognosis. Collectively, his research aims to guide policies and interventions that advance equitable and personalized approaches to prostate cancer prevention and early detection.
Speaker Information
Kevin Kensler, ScD, MHS
Organizers
Related Events
ⓘ Harvard Chan School hosts a diverse array of speakers, invited to share both scholarly research and personal perspectives. They do not speak for the School, and hosting them does not imply endorsement of their views, organizations, or employers.